| Biological Sciences | Lifetime | 22 | JP 2 | 99.99 |
| Immunology | Lifetime | 1 | JP 1 | 100.00 |
| Cancer Research | Lifetime | 29 | JP 1 | 99.83 |
| Molecular Biology | Lifetime | 688 | JP 17 | 99.65 |
| Oncology | Lifetime | 265 | JP 8 | 99.58 |
| Epidemiology | Lifetime | 540 | JP 12 | 99.33 |
| Emergency Medical Services | Lifetime | 488 | JP 3 | 95.41 |
| Microbiology | Lifetime | 389 | JP 6 | 92.37 |
| Parasitology | Lifetime | 719 | JP 13 | 81.65 |
| Immunology | 2021-2025 | 472 | JP 11 | 86.94 |
| Immune Response and Inflammation | Lifetime | 1 | JP 1 | 100.00 |
| interferon and immune responses | Lifetime | 1 | JP 1 | 100.00 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 2 | JP 1 | 99.98 |
| Inflammasome and immune disorders | Lifetime | 2 | JP 1 | 99.95 |
| NF-κB Signaling Pathways | Lifetime | 2 | JP 1 | 99.99 |
| Immune Cell Function and Interaction | Lifetime | 15 | JP 1 | 99.96 |
| Immune cells in cancer | Lifetime | 6 | JP 1 | 99.91 |
| Antimicrobial Peptides and Activities | Lifetime | 7 | JP 1 | 99.79 |
| Immunotherapy and Immune Responses | Lifetime | 89 | JP 2 | 99.83 |
| Influenza Virus Research Studies | Lifetime | 57 | JP 1 | 99.61 |
| RNA regulation and disease | Lifetime | 44 | JP 2 | 99.20 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 65 | JP 1 | 99.20 |
| Autophagy in Disease and Therapy | Lifetime | 149 | JP 11 | 98.90 |
| Pediatric health and respiratory diseases | Lifetime | 145 | JP 1 | 98.85 |
| IL-33, ST2, and ILC Pathways | Lifetime | 121 | JP 7 | 98.76 |
| T-cell and B-cell Immunology | Lifetime | 594 | JP 21 | 98.90 |
| RNA Research and Splicing | Lifetime | 611 | JP 26 | 98.29 |
| Neonatal Respiratory Health Research | Lifetime | 933 | JP 4 | 97.87 |
| Cell death mechanisms and regulation | Lifetime | 361 | JP 14 | 97.31 |
| Phagocytosis and Immune Regulation | Lifetime | 264 | JP 11 | 95.61 |
| Reproductive System and Pregnancy | Lifetime | 972 | JP 52 | 96.03 |
| Pharmacological Effects of Natural Compounds | Lifetime | 994 | JP 120 | 94.58 |
| Immune responses and vaccinations | Lifetime | 180 | JP 1 | 94.28 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 980 | JP 110 | 94.68 |
| Invertebrate Immune Response Mechanisms | Lifetime | 615 | JP 45 | 94.45 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 179 | JP 9 | 88.53 |
| Biomarkers in Disease Mechanisms | Lifetime | 478 | JP 41 | 87.06 |
| Inflammation biomarkers and pathways | Lifetime | 272 | JP 9 | 86.70 |
| Immune Response and Inflammation | 2021-2025 | 493 | JP 18 | 82.84 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 920 | JP 39 | 58.37 |
| NF-κB Signaling Pathways | 2021-2025 | 413 | JP 25 | 53.23 |
